Drug intelligence / Profile preview

human umbilical cord mesenchymal stem cell exosomes (Sixth Affiliated Hospital, Sun Yat-sen University)

Development stage: Unknown
Lead developer: The Sixth Affiliated Hospital of Sun Yat-Sen University
Modality: Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Cell Therapies
Administration: Intrauterine

Overview

Human umbilical cord mesenchymal stem cell (hUC-MSC) exosomes are extracellular vesicles derived from hUC-MSCs that contain a cargo of bioactive molecules, including proteins, lipids, and various RNA species (such as miRNAs). Developed by the Sixth Affiliated Hospital, Sun Yat-sen University, these exosomes are being investigated as a cell-free regenerative therapy for intrauterine adhesions (IUA) and thin endometrium. The therapeutic approach involves intrauterine perfusion of the exosomes following hysteroscopic surgery to promote endometrial repair. The mechanism of action is believed to involve paracrine signaling that modulates the local uterine environment, stimulates endometrial cell proliferation, enhances angiogenesis, and reduces subendometrial fibrosis. This modality aims to restore uterine cavity morphology and improve endometrial receptivity for embryo implantation, offering a potentially safer and more standardized alternative to direct stem cell transplantation.

Other names: hUC-MSC exosomesUmbilical Cord Mesenchymal Stem Cell Exosomes

Beyond the preview

Go deeper on human umbilical cord mesenchymal stem cell exosomes (Sixth Affiliated Hospital, Sun Yat-sen University).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on human umbilical cord mesenchymal stem cell exosomes (Sixth Affiliated Hospital, Sun Yat-sen University).

Explore the full profile